ReproCell Delnica

ReproCell PEG

PEG razmerje (Razmerje cene, dohodka in rasti) od ReproCell (4978.T) na dan 14. avg. 2026 je 0,31. V prejšnjem letu je PEG razmerje (Razmerje cene, dohodka in rasti) znašal −4,69 — sprememba za −106,67 % (višje).

PEG

0,31

YoY

−106,67%

Zadnja posodobitev:

PEG razmerje (Razmerje cene, dohodka in rasti) od ReproCell je 2026 0,31 . PEG razmerje (Razmerje cene, dohodka in rasti) od ReproCell je bil 2025 −4,69 . Pada za −106,67% višje v primerjavi s prejšnjim letom.
Access this data via the Eulerpool API

ReproCell Analiza delnic

Kaj dela ReproCell? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell je eno najbolj priljubljenih podjetij na Eulopoolu.

Pogosto zastavljena vprašanja o delnici ReproCell

PEG razmerje (Razmerje cene, dohodka in rasti) podjetja ReproCell znaša 0,31 v letu 2026.

PEG razmerje (Razmerje cene, dohodka in rasti) od ReproCell se je spremenil z −4,69 na 0,31, kar predstavlja spremembo za −106,67 %. Vrednost je višje kot v prejšnjem letu.

Na Eulopoolu najdete celovit zgodovinski razvoj PEG razmerje (Razmerje cene, dohodka in rasti) ReproCell od leta 2006 – z letnimi vrednostmi, grafi in podrobno analizo.

Razmerje PEG prilagodi razmerje P/E s pričakovano stopnjo rasti dohodka. PEG pod 1 lahko kaže na delnico, ki je podcenjena glede na njen potencial rasti.

PEG = Razmerje P/E / Pričakovana letna stopnja rasti EPS

Za evalvacijo PEG razmerje (Razmerje cene, dohodka in rasti)s je ključno primerjati s konkurenti v isti industriji in sektorju. Na Euloolu lahko najdete neposredne primerjave PEG razmerje (Razmerje cene, dohodka in rasti) z drugimi podjetji.

Dobra vrednost za se razlikuje glede na industrijo in fazo razvoja podjetja. Na Euloolu lahko primerjate PEG razmerje (Razmerje cene, dohodka in rasti)s ReproCell s podobnimi podjetji v sektorju in povprečjem industrije, da ocenite privlačnost.

Access this data via the Eulerpool API

Vrednotenje — ReproCell

Vse ključne metrike — ReproCell